Lexaria Bioscience
Earnings Surprise
Analysts estimated LEXX earnings of $-0.10 per share this quarter (Q2). LEXX's actual earnings were $-0.06 per share.
LEXX EPS surprise of 38.08%Analysts estimated LEXX earnings of $-0.13 per share this quarter (Q1). LEXX's actual earnings were $-0.07 per share.
LEXX EPS surprise of 47.21%Analysts estimated LEXX earnings of $-0.16 per share this quarter (Q4). LEXX's actual earnings were $-0.13 per share.
LEXX EPS surprise of 18.65%Analysts estimated LEXX earnings of $-0.16 per share this quarter (Q3). LEXX's actual earnings were $-0.21 per share.
LEXX EPS surprise of -31.41%Analysts estimated LEXX earnings of $-0.16 per share this quarter (Q2). LEXX's actual earnings were $-0.15 per share.
LEXX EPS surprise of 5.12%Analysts estimated LEXX earnings of $-0.12 per share this quarter (Q1). LEXX's actual earnings were $-0.16 per share.
LEXX EPS surprise of -30.72%Analysts estimated LEXX earnings of $-0.11 per share this quarter (Q4). LEXX's actual earnings were $-0.14 per share.
LEXX EPS surprise of -24.78%Analysts estimated LEXX earnings of $-0.11 per share this quarter (Q3). LEXX's actual earnings were $-0.13 per share.
LEXX EPS surprise of -23.34%Analysts estimated LEXX earnings of $-0.10 per share this quarter (Q2). LEXX's actual earnings were $-0.06 per share.
LEXX EPS surprise of 41.18%Analysts estimated LEXX earnings of $-0.11 per share this quarter (Q1). LEXX's actual earnings were $-0.13 per share.
LEXX EPS surprise of 15.86%